Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility
Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility

Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility

The inspection, conducted between December 9 and December 17, 2024, resulted in two procedural observations from the US FDA.

Manoj Reddy Sama Article rating: 4.3

The facility in question, Unit-V, is an active pharmaceutical ingredient (API) manufacturing site operated by Apitoria Pharma Private Ltd, a wholly owned subsidiary of Aurobindo Pharma, located in Pashamylaram Village, Telangana.

 

FIIs & DIIs Increase Stake: Pipes Manufacturer Breaks Breaks Ground on USD 100 Million Expansion in USA
FIIs & DIIs Increase Stake: Pipes Manufacturer Breaks Breaks Ground on USD 100 Million Expansion in USA

FIIs & DIIs Increase Stake: Pipes Manufacturer Breaks Breaks Ground on USD 100 Million Expansion in USA

The company recently broke ground on a USD 100 million expansion of its HFIW pipe manufacturing facility in Little Rock, Arkansas, USA.

Manoj Reddy Sama Article rating: 3.7

During the September to June quarter, FIIs increased the stake to 11.65 per cent from 10.51 per cent during the March to June quarter. Meanwhile, DIIs during the same period increased the stake from 9.74 per cent to 11.41 per cent.

 

370 Per Cent Returns: Multibagger Stock Delivers 25 Per Cent PAT Growth
370 Per Cent Returns: Multibagger Stock Delivers 25 Per Cent PAT Growth

370 Per Cent Returns: Multibagger Stock Delivers 25 Per Cent PAT Growth

The company reported a strong financial performance, with year-on-year (Y-o-Y) Profit After Tax (PAT) growth of 24.8 per cent to Rs 198 crore, up from Rs 158.60 crore in the same quarter last year.

Manoj Reddy Sama Article rating: 5.0

Thermax’s order book performance remained solid, with an order balance of Rs 11,593 crore, reflecting a 12.95 per cent increase over Rs 10,264 crore in the previous year’s quarter.

52-week high alert & FIIs increase stake: This multibagger company signs MoU worth Rs 700 crore with Tamil Nadu Government – know more here!
52-week high alert & FIIs increase stake: This multibagger company signs MoU worth Rs 700 crore with Tamil Nadu Government – know more here!

52-week high alert & FIIs increase stake: This multibagger company signs MoU worth Rs 700 crore with Tamil Nadu Government – know more here!

The stock gave multibagger returns of over 150 per cent from its 52-week low of Rs 575 per share and a whopping 5,280 per cent in a decade.

Kiran Shroff Article rating: 3.6

The stock gave multibagger returns of over 150 per cent from its 52-week low of Rs 575 per share and a whopping 5,280 per cent in a decade.

230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it?
230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it?

230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it?

The company has delivered returns of 14.5 per cent over the past 3 years and returns of 230 per cent over the past 5 years.

Siddharth Mane Article rating: 4.1

The company has a ROCE of 19.4 per cent and a ROE of 19.1 per cent.

Stock trading under Rs 5: Don't miss action in smallcap stock aiming to become ‘Zero Debt Company’ by 2024
Stock trading under Rs 5: Don't miss action in smallcap stock aiming to become ‘Zero Debt Company’ by 2024

Stock trading under Rs 5: Don't miss action in smallcap stock aiming to become ‘Zero Debt Company’ by 2024

The Company is an emerging player in the global arena of the high-end speciality chemicals.   

Karan Dsij Article rating: 3.8

The Company has a goal of becoming a 100 per cent debt free entity within FY 2023-2024 under Debt Reduction Program, on persistence and support extended by the promoters of the Company.

This mid-cap company wins new orders worth Rs 1,131 crore!
This mid-cap company wins new orders worth Rs 1,131 crore!

This mid-cap company wins new orders worth Rs 1,131 crore!

The company reported positive performance in its quarterly and annual financial statements.

Kiran Shroff Article rating: 4.0

The company reported positive performance in its quarterly and annual financial statements.

This mid-cap company receives order worth Rs 95.38 crore, do you own it?
This mid-cap company receives order worth Rs 95.38 crore, do you own it?

This mid-cap company receives order worth Rs 95.38 crore, do you own it?

Today, shares of this company surged 2.65 per cent from their previous closing of Rs 75.60 per share to the day’s high of Rs 777.60.

Kiran Shroff Article rating: 4.1

Today, shares of this company surged 2.65 per cent from their previous closing of Rs 75.60 per share to the day’s high of Rs 777.60.

T20 breakout stocks: Best swing trading stocks to keep an eye on!
T20 breakout stocks: Best swing trading stocks to keep an eye on!

T20 breakout stocks: Best swing trading stocks to keep an eye on!

Karan Dsij Article rating: 3.4

The chart of Nifty is not an encouraging one at all. Having said that, the sharp correction hauled weekly stochastic oscillators towards the oversold territory and we could see some pullback in the markets, considering the oversold nature of the markets. So, we have prepared a list of stocks based on the T20 breakout system that one can keep in their watchlist. 

KEC International bucks market trend and towers above!
KEC International bucks market trend and towers above!

KEC International bucks market trend and towers above!

Karan Dsij Article rating: 4.8

KEC International was one of the stocks, which was seen outperforming and bucking the negative trend of the market as it surged 1.42 per cent on Friday. So, what was the key catalyst for the stock, which helped it to outperform the market by a wide margin?  

DSIJ MINDSHARE

Mkt Commentary20-Dec, 2024

Swing Trading22-Dec, 2024

IPO Analysis20-Dec, 2024

Mindshare20-Dec, 2024

IPO Analysis20-Dec, 2024

Knowledge

MF15-Nov, 2024

General15-Nov, 2024

MF14-Nov, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR